Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 78

Sort by

Sort Order Select

Journal Articles

Heterogeneity of the Erythromyeloblastic Island (EMBI) Niche during Baseline and Stress Erythropoiesis

Katie Seu, Laurel Romano, Athina Ntoumaziou, Maria Stewart, Jason C Gardner, Robert Paulson, Yi Zheng, Matthew Kofron, Lionel Blanc, Nathan Salomonis, Theodosia A. Kalfa

Blood (2024) 144 (Supplement 1): 163.

https://doi.org/10.1182/blood-2024-212042

Published: 2024

Journal Articles

Loss of ATG5 in Humans Causes Syndromic Congenital Dyserythropoietic Anemia with Impaired Mitophagy in Late Stages of Terminal Erythropoiesis

Athina Ntoumaziou, Duc Nguyen, Yasmin Elgammal, Ammar Husami, Wenying Zhang, Kaitlin D Weaver, Jennifer L. Kasten, David D. Grier, Yi Zheng, Carolyn Lutzko, Mary Risinger, Jan Frayne, Katie Seu, Theodosia A. Kalfa

Blood (2024) 144 (Supplement 1): 1084.

https://doi.org/10.1182/blood-2024-210280

Published: 2024

Journal Articles

Inducible, Erythroid-Specific Knockout of Codanin-1 in Adult Mice Replicates Congenital Dyserythropoietic Anemia Type-Ia

Corbin R Azucenas, Aikaterini Voulgaridou, Maria Stewart, Athina Ntoumaziou, Yasmin Elgammal, Katie Seu, Theodosia A. Kalfa

Blood (2024) 144 (Supplement 1): 1071.

https://doi.org/10.1182/blood-2024-208959

Published: 2024

Journal Articles

The Dominant Negative Acting VPS4A E228Q Mutation Causes Dyserythropoiesis in Human iPSC-Derived Erythroblast Cultures That Phenocopies Cimdag Syndrome-Associated Anemia

Courtney Gatterdam, Sana Emberesh, Yasmin Elgammal, Carolyn Lutzko, Lionel Blanc, Jose Cancelas, Theodosia A. Kalfa, Katie Seu

Blood (2024) 144 (Supplement 1): 2458.

https://doi.org/10.1182/blood-2024-211628

Published: 2024

Journal Articles

Erythrocyte Disorders Mimicking Congenital Dyserythropoietic Anemia Based on Bone Marrow Pathology Exposed By Genetic Evaluation

Jacopo Ceolan, Katie Seu, Athina Ntoumaziou, Yasmin Elgammal, Sana Emberesh, Lisa Bilston, Donald Richards, Kathryn E. Dickerson, Satheesh Chonat, Natalia Rydz, Carolyn Lutzko, Ammar Husami, Wenying Zhang, Theodosia A. Kalfa

Blood (2023) 142 (Supplement 1): 2459.

https://doi.org/10.1182/blood-2023-189140

Published: 2023

Journal Articles

Congenital Dyserythropoietic Anemia Type II: An Update from the Congenital Dyseryhtropoietic Anemia Registry of North America (CDAR)

Yasmin Elgammal, Mary Risinger, Ammar Husami, Joseph Walden, Sweta Gupta, Niketa C. Shah, James Boyer, Yasmina L. Abajas, Michael Winstead, David W. Miller, Viviana Vidal-Anaya, Adrianna Vlachos, Ashutosh Lal, Arthur K. Ritchey, Robert Lorsbach, Wenying Zhang, Theodosia A. Kalfa, Omar Niss

Blood (2023) 142 (Supplement 1): 1079.

https://doi.org/10.1182/blood-2023-189389

Published: 2023

Journal Articles

Effects of L-Glutamine on Biomarkers of Response in Sickle Cell Disease: A Pharmacokinetics-Pharmacodynamics Analysis

Alina Sadaf, Min Dong, Jennifer Korpik, Amanda Pfeiffer, Theodosia A. Kalfa, Teresa S. Latham, Alexander A. Vinks, Russell E. Ware, Charles T. Quinn

Blood (2023) 142 (Supplement 1): 1145.

https://doi.org/10.1182/blood-2023-180312

Published: 2023

Journal Articles

Irf5 Expression in Macrophages Contributes to Iron Regulation within Erythromyeloblastic Islands

Rachel Josselsohn, Anshul Vagrecha, Margaret LaPan, Julien Papoin, Jonah Kamen, Young Min Cho, Riaz Rao, Laurel Romano, Nathan Salomonis, Theodosia A. Kalfa, Lionel Blanc, Betsy J. Barnes

Blood (2023) 142 (Supplement 1): 920.

https://doi.org/10.1182/blood-2023-189421

Published: 2023

Journal Articles

Inducible Knockout of Codanin-1: An Adult Mouse Model of Congenital Dyserythropoietic Anemia Type-I

Corbin R Azucenas, Maria Stewart, Aikaterini Voulgaridou, Katie Seu, Theodosia A. Kalfa

Blood (2023) 142 (Supplement 1): 2450.

https://doi.org/10.1182/blood-2023-187075

Published: 2023

Journal Articles

Rapid Assessment of Hemoglobin-Oxygen Dissociation

Zoe Sekyonda, Cissy Kityo, Yasmin Elgammal, Theodosia A. Kalfa, Ozan Akkus, Umut A. Gurkan

Blood (2023) 142 (Supplement 1): 2270.

https://doi.org/10.1182/blood-2023-187503

Published: 2023

Journal Articles

Leveraging Transcriptomic Data to Study Erythromyeloblastic Island (EMBI) Macrophages: Using Spic-GFP As a Marker for Embi Macrophages

Laurel Romano, Athina Ntoumaziou, Jason C Gardner, Maria Stewart, Robert Paulson, Nathan Salomonis, Lionel Blanc, Katie Seu, Theodosia A. Kalfa

Blood (2023) 142 (Supplement 1): 3832.

https://doi.org/10.1182/blood-2023-187162

Published: 2023

Journal Articles

A Novel Beta Globin Frameshift Mutation Causing Autosomal Dominant Beta Thalassemia

Lisa Bilston, Kelsey Uminski, Theodosia A. Kalfa, Ammar Husami, M. Dawn Goodyear, Natalia Rydz

Blood (2023) 142 (Supplement 1): 1105.

https://doi.org/10.1182/blood-2023-187014

Published: 2023

Journal Articles

De Novo Germline DHX38 Variant Associated with Alternative Splicing of Multiple Transcripts in Iron-Related Pathways in a Patient with Atypical Congenital Dyserythropoietic Anemia with Ring Sideroblasts

Aikaterini Voulgaridou, Yasmin Elgammal, Ammar Husami, Sana Emberesh, Katie Seu, Mahesh Ramamoorthy, Lisa Trump, Nathaniel Barasa, Adam S. Nelson, Robert B. Lorsbach, Laurel Romano, Nathan A. Salomonis, Wenying Zhang, Carolyn Lutzko, Theodosia A. Kalfa

Blood (2022) 140 (Supplement 1): 1234–1235.

https://doi.org/10.1182/blood-2022-166509

Published: 2022

Journal Articles

Dominant-Negative VPS4A Mutations Causing Congenital Dyserythropoietic Anemia Disrupt Iron Trafficking of Terminal Erythropoiesis

Katie Seu, Aikaterini Voulgaridou, Maria Stewart, Jessica Meznarich, Clarissa Johnson, Harald Junge, Bryan Mackenzie, Lionel Blanc, Jose A. Cancelas, Theodosia A. Kalfa

Blood (2022) 140 (Supplement 1): 8190–8191.

https://doi.org/10.1182/blood-2022-170843

Published: 2022

Journal Articles

Erythroblastic islands foster granulopoiesis in parallel to terminal erythropoiesis

Laurel Romano, Katie G. Seu, Julien Papoin, David E. Muench, Diamantis Konstantinidis, André Olsson, Katrina Schlum, Kashish Chetal, Joel Anne Chasis, Narla Mohandas, Betsy J. Barnes, Yi Zheng, H. Leighton Grimes, Nathan Salomonis, Lionel Blanc, Theodosia A. Kalfa

Blood (2022) 140 (14): 1621–1634.

https://doi.org/10.1182/blood.2022015724

Published: 2022

Includes: Supplemental data

Journal Articles

SERF1 Is Required for G-CSF Resistance of Start-Codon Mutant ELANE Granulocytic Precursors

Ramesh C Nayak, Lisa Trump, Sana Emberesh, Yarim Lee, Abhishek K Singh, Ashley M Wellendorf, Marshall S. Horwitz, Theodosia A. Kalfa, Carolyn Lutzko, Jose A. Cancelas

Blood (2021) 138 (Supplement 1): 433.

https://doi.org/10.1182/blood-2021-150899

Published: 2021

Journal Articles

Etavopivat, an Allosteric Activator of Pyruvate Kinase-R, Improves Sickle RBC Functional Health and Survival and Reduces Systemic Markers of Inflammation and Hypercoagulability in Patients with Sickle Cell Disease: An Analysis of Exploratory Studies in a Phase 1 Study

Theodosia A. Kalfa, Marilyn J. Telen, Santosh L. Saraf, R. Clark Clark Brown, Katie Giger Seu, Sandra K. Larkin, Maria D. Ribadeneira, Patricia Schroeder, Eric Wu, Patrick Kelly, Frans A. Kuypers

Blood (2021) 138 (Supplement 1): 8.

https://doi.org/10.1182/blood-2021-147078

Published: 2021

Journal Articles

Overexpression of Human TLR8 Causes Fatal Anemia in SLE-Prone Mice By Altering the Bone Marrow Erythropoietic Niche

Anne Davidson, Naomi Maria, Julien Papoin, Chirag Raparia, Zeguo Sun, Weijia Zhang, Theodosia A. Kalfa, Robert Paulson, Lionel Blanc

Blood (2021) 138 (Supplement 1): 1989.

https://doi.org/10.1182/blood-2021-145465

Published: 2021

Journal Articles

Trial in Progress: A Phase 2, Open-Label Study Evaluating the Safety and Efficacy of the PKR Activator Etavopivat (FT-4202) in Patients with Thalassemia or Sickle Cell Disease

Ashutosh Lal, R. Clark Clark Brown, Thomas D. Coates, Theodosia A. Kalfa, Janet L. Kwiatkowski, Julie Brevard, Von Potter, Ken W. Wood, Sujit Sheth

Blood (2021) 138 (Supplement 1): 4162.

https://doi.org/10.1182/blood-2021-145752

Published: 2021

Journal Articles

Activation of Pyruvate Kinase-R with Etavopivat (FT-4202) Is Well Tolerated, Improves Anemia, and Decreases Intravascular Hemolysis in Patients with Sickle Cell Disease Treated for up to 12 Weeks

R. Clark Clark Brown, Santosh L. Saraf, Kimberly Cruz, Modupe Idowu, Theodosia A. Kalfa, James Geib, Sanjeev Forsyth, Patricia Schroeder, Eric Wu, Patrick Kelly, Marilyn J. Telen

Blood (2021) 138 (Supplement 1): 9.

https://doi.org/10.1182/blood-2021-147091

Published: 2021

NARROW

Heterogeneity of the Erythromyeloblastic Island (EMBI) Niche during Baseline and Stress Erythropoiesis

Loss of ATG5 in Humans Causes Syndromic Congenital Dyserythropoietic Anemia with Impaired Mitophagy in Late Stages of Terminal Erythropoiesis

Inducible, Erythroid-Specific Knockout of Codanin-1 in Adult Mice Replicates Congenital Dyserythropoietic Anemia Type-Ia

The Dominant Negative Acting VPS4A E228Q Mutation Causes Dyserythropoiesis in Human iPSC-Derived Erythroblast Cultures That Phenocopies Cimdag Syndrome-Associated Anemia

Erythrocyte Disorders Mimicking Congenital Dyserythropoietic Anemia Based on Bone Marrow Pathology Exposed By Genetic Evaluation

Congenital Dyserythropoietic Anemia Type II: An Update from the Congenital Dyseryhtropoietic Anemia Registry of North America (CDAR)

Effects of L-Glutamine on Biomarkers of Response in Sickle Cell Disease: A Pharmacokinetics-Pharmacodynamics Analysis

Irf5 Expression in Macrophages Contributes to Iron Regulation within Erythromyeloblastic Islands

Inducible Knockout of Codanin-1: An Adult Mouse Model of Congenital Dyserythropoietic Anemia Type-I

Rapid Assessment of Hemoglobin-Oxygen Dissociation

Leveraging Transcriptomic Data to Study Erythromyeloblastic Island (EMBI) Macrophages: Using Spic-GFP As a Marker for Embi Macrophages

A Novel Beta Globin Frameshift Mutation Causing Autosomal Dominant Beta Thalassemia

De Novo Germline DHX38 Variant Associated with Alternative Splicing of Multiple Transcripts in Iron-Related Pathways in a Patient with Atypical Congenital Dyserythropoietic Anemia with Ring Sideroblasts

Dominant-Negative VPS4A Mutations Causing Congenital Dyserythropoietic Anemia Disrupt Iron Trafficking of Terminal Erythropoiesis

Erythroblastic islands foster granulopoiesis in parallel to terminal erythropoiesis

SERF1 Is Required for G-CSF Resistance of Start-Codon Mutant ELANE Granulocytic Precursors

Etavopivat, an Allosteric Activator of Pyruvate Kinase-R, Improves Sickle RBC Functional Health and Survival and Reduces Systemic Markers of Inflammation and Hypercoagulability in Patients with Sickle Cell Disease: An Analysis of Exploratory Studies in a Phase 1 Study

Overexpression of Human TLR8 Causes Fatal Anemia in SLE-Prone Mice By Altering the Bone Marrow Erythropoietic Niche

Trial in Progress: A Phase 2, Open-Label Study Evaluating the Safety and Efficacy of the PKR Activator Etavopivat (FT-4202) in Patients with Thalassemia or Sickle Cell Disease

Activation of Pyruvate Kinase-R with Etavopivat (FT-4202) Is Well Tolerated, Improves Anemia, and Decreases Intravascular Hemolysis in Patients with Sickle Cell Disease Treated for up to 12 Weeks

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only